IDEAYA Biosciences, Inc. (IDYA) Financials

IDYA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.3 billion 110.8 million
March 31, 2026 1.0 billion 93.1 million
Dec. 31, 2025 1.1 billion 86.4 million
Sept. 30, 2025 1.2 billion 93.1 million

IDYA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -165.2 million 31.2 million
March 31, 2026 -76.1 million 14.5 million
Dec. 31, 2025 -90.8 million 11.8 million
Sept. 30, 2025 142.2 million 12.2 million

IDYA Net Income

No data available :(

IDYA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 829.0 million - 29.3 million
March 31, 2026 671.2 million 28.3 million 28.6 million
Dec. 31, 2025 639.4 million 27.6 million 27.6 million
Sept. 30, 2025 786.9 million - 27.2 million

IDYA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 92.1 million
March 31, 2026 88.7 million
Dec. 31, 2025 88.6 million
Sept. 30, 2025 89.7 million

IDYA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 1.8 million 108.7 million 22.5 million -
March 31, 2026 967000 95.7 million 19.4 million -
Dec. 31, 2025 333000 86.6 million 18.8 million -
Sept. 30, 2025 42000 83.0 million 16.4 million -

IDYA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 8.9 million -
March 31, 2026 6.6 million 1.1 million
Dec. 31, 2025 10.9 million 86.6 million
Sept. 30, 2025 207.8 million 83.0 million

IDYA Revenue by Segment
Graph available only for paid members. Upgrade to see it.

IDYA

Price: $36.30

52 week price:
22.09
40.58

Earnings Per Share: -1.92 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 546053

Market Capitalization: 3.6 billion

Links: